Candel Therapeutics (CADL) Shares Issued (2020 - 2025)

Candel Therapeutics (CADL) has 6 years of Shares Issued data on file, last reported at $4.1 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Issued fell 8.62% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (down 8.62% YoY), and the FY2025 full-year result was $4.1 million, down 8.62% from the prior year.
• Shares Issued climbed to $4.1 million in Q4 2025, from $3.9 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $6.2 million in Q3 2022 to a low of $1.1 million in Q2 2021.
• A 5-year average of $4.0 million and a median of $4.1 million in 2025 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued soared 437.37% in 2022 and sank 71.67% in 2023, its largest moves.
• Tracing CADL's Shares Issued over 5 years: stood at $4.8 million in 2021, then gained by 18.02% to $5.6 million in 2022, then grew by 0.38% to $5.7 million in 2023, then retreated by 20.83% to $4.5 million in 2024, then declined by 8.62% to $4.1 million in 2025.
• Business Quant data shows CADL's Shares Issued at $4.1 million in Q4 2025, $3.9 million in Q3 2025, and $2.0 million in Q2 2025.